Industri

Mr Shaunak J Dave, CEO & MD, Antares Vision Group

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Mr ...

Dr Vellaian Karuppaiah, COO, Acme and Immacule Group

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Dr ...

Mr Enoch Daniel, Director, Svan Analytical Instruments

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Mr ...

Panel Discussion: Sterility & compliance 2026: What glo...

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Pan...

Mr Taabish Siddiqui, Product Manager (Sterile Transfer)...

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Mr ...

Mr Daneshwar Kumar, Head – MSAT, Dr Reddy’s Laboratories

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Mr ...

Mr Lenin Babu N, MD, Omega Scientific Instruments

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Mr ...

Panel Discussion: Beyond generics: Moving into complex ...

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Pan...

Panel Discussion: India as an injectable hub: Growing C...

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Pan...

Mr Sridhar Balasubramanian, Head Quality – Sterile / Pa...

Injectable Innovations Conclave 2026 | 10th April 2026 | Hyderabad The post Mr ...

Venus Remedies receives Saudi FDA approval for Plerixafor

Venus Remedies, among the world’s ten largest fixed-dosage injectable manufactu...

Platinum Industries collaborates with Dr Abhigyan Upadh...

Platinum Industries, an innovation-driven specialty chemicals company announced...

CDSCO clarifies injectables cannot be marketed as cosme...

Central Drugs Standard Control Organisation (CDSCO) has issued a public notice ...

Concept Life Sciences and OpenBench partner on drug dis...

The collaboration aims to accelerate hit identification for these companies thro...

Gilead Sciences acquires Tubulis for $5bn

First announced last month, the move aims to advance Gilead’s oncology portfolio...

India’s first CAR T-Cell therapy shows durable results

In a major milestone in Indian oncology care, Immuneel Therapeutics’ Made-In-In...